Jeff Spitzner

MatchTx is a Big Data healthcare analytics software company with unique patent-pending technology. The solution enables matching patients to cancer drugs and clinical trials with novel methods to find best matches using genetic, clinical, and outcome data. The technology was licensed exclusively from partner The Ohio State University. MatchTx wasawarded a competitive $125,000 grant from the Third Frontier Program of the State of Ohio. Initial equity investment enabled commercial product development and clinical data validation of the technology (proven out in peer-reviewed publications on both cancer cell-lines and cancer patient studies).